Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
CardioComm SolutionsEKGGF 3-Year ROIIC % is -525.00 as of Dec. 2025. The stock has 8 warning signs investors should review. Among 620 Healthcare Providers & Services companies, CardioComm Solutions ranks worse than 97.74% on this metric.
3-Year Return on Invested Incremental Capital (3-Year ROIIC %) measures the change in earnings as a percentage of change in investment over 3-year.
CardioComm Solutions's 3-Year ROIIC % for the quarter that ended in Dec. 2025 was -525.00%. High ROIIC is generally an indication that your business is capital efficient or has a higher operating leverage.
The industry rank for CardioComm Solutions's 3-Year ROIIC % or its related term are showing as below:
EKGGF's 3-Year ROIIC % is ranked worse than 97.74% of 620
companies
in the Healthcare Providers & Services industry
Industry Median: 3.47
vs EKGGF: -525.00
Return on Incremental Invested Capital (ROIIC) is an extension of Return on Investment Capital (ROIC). ROIC % tells investors how efficiently that profitability is earned per dollar of company capital. ROIIC narrows the focus even further and shows how profitable each additional unit of capital investment could be. ROIIC % is a more powerful metric than ROIC because it measures how much money the company can generate going forward on future capital investments.
High ROIIC is generally an indication that your business is capital efficient or has a higher operating leverage.
Be Aware
It's important to keep in mind that when tracking ROIIC, the metric is better suited to forecasting the trend of future returns rather than measuring current return on investment.
CardioComm Solutions 3-Year ROIIC % Related Terms
CardioComm Solutions 3-Year ROIIC % Historical Data
* Premium members only.
The historical data trend for CardioComm Solutions's 3-Year ROIIC % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
EKGGF vs VEEV, BTSG, HQY: 3-Year ROIIC % Comparison
For the Health Information Services subindustry, CardioComm Solutions's 3-Year ROIIC %, along with its competitors' market caps and 3-Year ROIIC % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
CardioComm Solutions 3-Year ROIIC % vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, CardioComm Solutions's 3-Year ROIIC % distribution charts can be found below:
* The bar in red indicates where CardioComm Solutions's 3-Year ROIIC % falls into.
CardioComm Solutions's 3-Year ROIIC % for the quarter that ended in Dec. 2025 is calculated as:
3-Year ROIIC %
=
3-Year Incremental Net Operating Profit After Taxes (NOPAT)**
/
3-Year Incremental Invested Capital**
=
( -0.404 (Dec. 2025) - -0.054 (Dec. 2022) )
/
( 0.473 (Dec. 2025) - 0.414 (Dec. 2022) )
=
-0.35
/
0.059
=
-593.22%***
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
** Annual data of NOPAT and Invested Capital was used to calculate 3-Year ROIIC %.
*** Please be aware that the ROIIC (Return on Invested Capital) calculations are based on company-level data using the primary share class. The calculated data provided is for demonstration purposes and may slightly differ from the results displayed in the title due to potential variations caused by currency exchange rate differences throughout the year.
CardioComm Solutions (EKGGF) has a 3-Year ROIIC % of -525.00 as of Dec. 2025. 3-Year ROIIC % measures the change in earnings as a percentage of change in investment over 3-year. View historical data on CardioComm Solutions and its competitors. According to the industry distribution chart, CardioComm Solutions ranks #606 out of 620 companies in the Healthcare Providers & Services industry, placing it in the top 97.7%.
Is CardioComm Solutions' 3-Year ROIIC % too high?
CardioComm Solutions' current 3-Year ROIIC % is -525.00. Based on the distribution chart, CardioComm Solutions ranks #606 out of 620 companies in the Healthcare Providers & Services industry, which is in the bottom quartile relative to peers.
How does CardioComm Solutions' 3-Year ROIIC % compare to VEEV and BTSG?
According to the Healthcare Providers & Services industry distribution chart, CardioComm Solutions ranks #606 out of 620 companies for 3-Year ROIIC %. This places CardioComm Solutions in the lower half of its industry. The industry median 3-Year ROIIC % is 3.47. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good 3-Year ROIIC % for a Healthcare Providers & Services company?
The median 3-Year ROIIC % among Healthcare Providers & Services companies is 3.47, based on 620 companies in the industry. Companies in the top quartile (top 25%) have a 3-Year ROIIC % significantly above this median, while those in the bottom quartile fall well below. However, 3-Year ROIIC % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high 3-Year ROIIC % mean?
A high 3-Year ROIIC % can signal that a stock is expensive relative to its fundamentals. 3-Year ROIIC % measures the change in earnings as a percentage of change in investment over 3-year. View historical data on CardioComm Solutions and its competitors. For the Healthcare Providers & Services industry, the median 3-Year ROIIC % is 3.47 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. CardioComm Solutions's current 3-Year ROIIC % is -525.00. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is CardioComm Solutions stock overvalued right now?
CardioComm Solutions (EKGGF) has a current 3-Year ROIIC % of -525.00. The current 3-Year ROIIC % is -525.00. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is 3-Year ROIIC % calculated?
3-Year ROIIC % is calculated from a company's financial statements. For CardioComm Solutions (EKGGF), the current 3-Year ROIIC % is -525.00 as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
CardioComm Solutions Inc develops software, hardware and core laboratory reading services related to electrocardiogram (ECG) and ambulatory arrhythmia monitoring systems for medical and consumer markets globally. The Company has one operating segment, which involves the development of software and the sale of ECG recording equipment and ECG reading services for the cardiology field. Substantially all the Company's operations, assets, and employees are in Canada. Revenue is earned in Canada and the United States. Its products are GEMS Sirona, GEMS WIN, Trident Pro 40L, HeartCheck CardiBeat - Mobile ECG Device, HeartCheck SMART Monitoring, and Others.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
EKGGF has been successfully added to your 
